STEPHAN ANTHONY BILLSTEIN
Medical Practice in Franklin Lakes, NJ
License number
Pennsylvania MD007051E
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
2
Franklin Lakes, NJ 07417
Pennsylvania
Pennsylvania
Personal information
See more information about STEPHAN ANTHONY BILLSTEIN at radaris.comName
Address
Phone
580 Ewing Ave, Franklin Lks, NJ 07417
Wyckoff, NJ
580 Ewing Ave, Franklin Lakes, NJ 07417
580 Ewing Ave, Franklin Lks, NJ 07417
Professional information
Stephan Billstein - Franklin Lakes, NJ
Work:
BVMI
Bergen Volunteer Medical Initiative New Jersey Medical Association New Jersey Medical Association New Jersey Medical Association New Jersey Medical Association New Jersey Medical Association International Society of Dermatology Dermatology, Mt. Sinai, School of Medicine
Clinical Assistant Professor Membership Membership Pacific Dermatology Association The Medicine Company
Vice President, Medical Novartis Pharmaceuticals
Senior Medical Consultant Antimicrobial Research
Executive Director - Global Head Brand Clinical Leader Executive Director Sandoz Pharmaceuticals
Medical Director - Dermatology/Endocrinology Sandoz Pharmaceuticals
Senior Associate Medical Director Roche Laboratories
Director, Medical Services Associate Medical Director - San Francisco, CA On Staff of Sacramento Medical Center and University of California - Newark, NJ
Staff Dermatologist San Francisco Medical Society - San Francisco, CA Dermatology Clinics/Consulting - San Francisco, CA
Director dermatology Dermatology Clinics/Consulting - Sacramento, CA
Dermatology consultant Dermatology at University of California Medical School
Associate Professor Dermatology Clinics/Consulting - Sacramento, CA
Pediatric dermatology clinic director Dermatology at University of California Medical School - Davis, CA
Assistant Clinical Professor Dermatology at University of California Medical School
Associate Clinical Professor Membership
Former Chairman, Preventative Medicine Section On Staff of Sacramento Medical Center and University of California - San Francisco, CA Dermatology at University of California Medical School - San Francisco, CA
Clinical Instructor Roche Laboratories
Assistant Medical Director Membership
Former Chairman, Sexually Transmitted Diseases Task Force Dermatology Clinics/Consulting - Folsom, CA
Consultant dermatologist California Public Health Association
Northern Division Board Member California Public Health Association Sacramento County Health Agency Mather AFB - Rancho Cordova, CA
Dermatology Consultant Private Dermatology Practice - Reno, NV Private Dermatology Practice - Reno, NV
Dermatology consultant U.S. Army
Captain
Bergen Volunteer Medical Initiative New Jersey Medical Association New Jersey Medical Association New Jersey Medical Association New Jersey Medical Association New Jersey Medical Association International Society of Dermatology Dermatology, Mt. Sinai, School of Medicine
Clinical Assistant Professor Membership Membership Pacific Dermatology Association The Medicine Company
Vice President, Medical Novartis Pharmaceuticals
Senior Medical Consultant Antimicrobial Research
Executive Director - Global Head Brand Clinical Leader Executive Director Sandoz Pharmaceuticals
Medical Director - Dermatology/Endocrinology Sandoz Pharmaceuticals
Senior Associate Medical Director Roche Laboratories
Director, Medical Services Associate Medical Director - San Francisco, CA On Staff of Sacramento Medical Center and University of California - Newark, NJ
Staff Dermatologist San Francisco Medical Society - San Francisco, CA Dermatology Clinics/Consulting - San Francisco, CA
Director dermatology Dermatology Clinics/Consulting - Sacramento, CA
Dermatology consultant Dermatology at University of California Medical School
Associate Professor Dermatology Clinics/Consulting - Sacramento, CA
Pediatric dermatology clinic director Dermatology at University of California Medical School - Davis, CA
Assistant Clinical Professor Dermatology at University of California Medical School
Associate Clinical Professor Membership
Former Chairman, Preventative Medicine Section On Staff of Sacramento Medical Center and University of California - San Francisco, CA Dermatology at University of California Medical School - San Francisco, CA
Clinical Instructor Roche Laboratories
Assistant Medical Director Membership
Former Chairman, Sexually Transmitted Diseases Task Force Dermatology Clinics/Consulting - Folsom, CA
Consultant dermatologist California Public Health Association
Northern Division Board Member California Public Health Association Sacramento County Health Agency Mather AFB - Rancho Cordova, CA
Dermatology Consultant Private Dermatology Practice - Reno, NV Private Dermatology Practice - Reno, NV
Dermatology consultant U.S. Army
Captain
Education:
University of California, Berkeley - Berkeley, CA
MPH in epidemiology and biomedical sciences UCLA - Los Angeles, CA
Dermatology Residency Pennsylvania State University
B.S. Jefferson Medical College
M.D.
MPH in epidemiology and biomedical sciences UCLA - Los Angeles, CA
Dermatology Residency Pennsylvania State University
B.S. Jefferson Medical College
M.D.
Dr. Stephan A Billstein, Franklin Lakes NJ - MD (Doctor of Medicine)
Specialties:
Dermatology, Preventive Public Health Medicine, Public Health & General Preventive Medicine
Address:
580 Ewing Ave, Franklin Lakes 07417
(201) 848-8451 (Phone), (201) 848-9191 (Fax)
(201) 848-8451 (Phone), (201) 848-9191 (Fax)
Certifications:
Dermatology, 1969, Public Health
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Thomas Jefferson University
Graduated: 1962
Los Angeles County-U S C Medical Center
State Calif
V a Greater Healthcare-Los Angeles
Thomas Jefferson University
Graduated: 1962
Los Angeles County-U S C Medical Center
State Calif
V a Greater Healthcare-Los Angeles
Pharmaceutical Combinations And Their Use In Treating Gastrointestinal And Abdominal Viscera Disorders
US Patent:
2004009, May 13, 2004
Filed:
Nov 6, 2003
Appl. No.:
10/702688
Inventors:
Stephan Billstein - Franklin Lakes NJ, US
Peter Dumovic - Mendham NJ, US
Nicola Franco - Sondersdorf, FR
Mark Iwicki - Long Valley NJ, US
Hans-Jurgen Pfannkuche - Weil am Rhein, DE
Edward Wilusz - Pittstown NJ, US
Peter Dumovic - Mendham NJ, US
Nicola Franco - Sondersdorf, FR
Mark Iwicki - Long Valley NJ, US
Hans-Jurgen Pfannkuche - Weil am Rhein, DE
Edward Wilusz - Pittstown NJ, US
International Classification:
A61K031/5513, A61K031/445
US Classification:
514/221000, 514/282000, 514/317000
Abstract:
The present invention relates to a combination of a first agent including either a 5-HTreceptor agonist or antagonist or a 5-HTreceptor antagonist and a co-agent and pharmaceutical compositions and formulations containing the combination. The present invention also relates to a method of treating a gastrointestinal and abdominal viscera disorder by administering the pharmaceutical compositions to a patient. The pharmaceutical compositions may also be employed as laxatives, to prepare a patient for colonoscopy and to regulate and stabilize enterochromaffin cell secretory, pain and motility mechanisms, afferent fiber activity and GI and lower abdominal smooth muscle cells. The dosage is preferably oral and administration is preferably once or twice a day. The preferred first agent is tegaserod.
Pharmaceutical Combinations And Their Use In Treating Gastrointestinal And Abdominal Viscera Disorders
US Patent:
2008009, Apr 17, 2008
Filed:
Oct 9, 2007
Appl. No.:
11/973404
Inventors:
Stephan Billstein - Franklin Lakes NJ, US
Peter Dumovic - Mendham NJ, US
Nicola Franco - Sondersdorf, FR
Mark Iwicki - Long Valley NJ, US
Hans-Juergen Pfannkuche - Weil am Rhein, DE
Edward Wilusz - Fanwood NJ, US
Peter Dumovic - Mendham NJ, US
Nicola Franco - Sondersdorf, FR
Mark Iwicki - Long Valley NJ, US
Hans-Juergen Pfannkuche - Weil am Rhein, DE
Edward Wilusz - Fanwood NJ, US
International Classification:
A61K 31/404, A61K 31/4439, A61P 1/00
US Classification:
514338000, 514415000
Abstract:
The present invention relates to a combination of a first agent including either a 5-HTreceptor agonist or antagonist or a 5-HTreceptor antagonist and a co-agent and pharmaceutical compositions and formulations containing the combination. The present invention also relates to a method of treating a gastrointestinal and abdominal viscera disorder by administering the pharmaceutical compositions to a patient. The pharmaceutical compositions may also be employed as laxatives, to prepare a patient for colonoscopy and to regulate and stabilize enterochromaffin cell secretory, pain and motility mechanisms, afferent fiber activity and GI and lower abdominal smooth muscle cells. The dosage is preferably oral and administration is preferably once or twice a day. The preferred first agent is tegaserod.
Famciclovir For The Treatment Of Recurrent Herpes Labialis Using A One-Day Treatment
US Patent:
2012032, Dec 27, 2012
Filed:
Sep 7, 2012
Appl. No.:
13/606219
Inventors:
Stephan Anthony Billstein - Franklin Lakes NJ, US
Robert Charnas - Westlake Village CA, US
Spotswood Spruance - Salt Lake City UT, US
Robert Charnas - Westlake Village CA, US
Spotswood Spruance - Salt Lake City UT, US
International Classification:
A61K 31/52, A61P 31/22
US Classification:
5142634
Abstract:
A method for the treatment of recurrent herpes labialis in mammals, including humans, which method comprises administering to the mammal in need of such treatment, and effective amount of penciclovir or famciclovir, or a pharmaceutically acceptable salt thereof for a period of one day.
Famciclovir For The Treatment Of Recurrent Herpes Labialis Using A One-Day Treatment
US Patent:
2012032, Dec 27, 2012
Filed:
Sep 6, 2012
Appl. No.:
13/604955
Inventors:
Stephan Anthony Billstein - Franklin Lakes NJ, US
Robert Charnas - Westlake Village CA, US
Spotswood Spruance - Salt Lake City UT, US
Robert Charnas - Westlake Village CA, US
Spotswood Spruance - Salt Lake City UT, US
International Classification:
A61K 31/52, A61P 31/22
US Classification:
5142634
Abstract:
A method for the treatment of recurrent herpes labialis in mammals, including humans, which method comprises administering to the mammal in need of such treatment, an effective amount of penciclovir or famciclovir, or a pharmaceutically acceptable salt thereof for a period of one day.
Famciclovir For The Treatment Of Recurrent Genital Herpes Labialis With A One Day Application
US Patent:
2012008, Apr 12, 2012
Filed:
Dec 20, 2011
Appl. No.:
13/330979
Inventors:
Stephan Anthony BILLSTEIN - Franklin Lakes NJ, US
Robert Charnas - Westlake Village CA, US
Spotswood Spruance - Salt Lake City UT, US
Robert Charnas - Westlake Village CA, US
Spotswood Spruance - Salt Lake City UT, US
International Classification:
A61K 31/52, A61P 31/22
US Classification:
5142634
Abstract:
A method for the treatment of recurrent herpes labialis in mammals, including humans, which method comprises administering to the mammal in need of such treatment, an effective amount of penciclovir or famciclovir, or a pharmaceutically acceptable salt thereof for a period of one day.
Penciclovir Or Famciclovir For Treatment Of Recurrent Genital Herpes With A One-Day Application
US Patent:
2011025, Oct 20, 2011
Filed:
Feb 16, 2011
Appl. No.:
13/028680
Inventors:
Stephan BILLSTEIN - Franklin Lakes NJ, US
Estate of Stephen Sacks - Vancouver, CA
Marika Sacks - Vancouver, CA
Estate of Stephen Sacks - Vancouver, CA
Marika Sacks - Vancouver, CA
International Classification:
A61K 31/52, A61P 31/22
US Classification:
5142631
Abstract:
A method for the treatment of recurrent genital herpes, in mammals, including humans, which method comprises administering to the mammal in need of such treatment, an effective amount of penciclovir or famciclovir, or a pharmaceutically acceptable salt thereof for a treatment period of one day.
Famciclovir For The Treatment Of Recurrent Herpes Labialis Using A One-Day Treatment
US Patent:
2010029, Nov 25, 2010
Filed:
Jul 1, 2010
Appl. No.:
12/803649
Inventors:
Stephan Anthony Billstein - Franklin Lakes NJ, US
Robert Charnas - Westlake Village CA, US
Spotswood Spruance - Salt Lake City UT, US
Robert Charnas - Westlake Village CA, US
Spotswood Spruance - Salt Lake City UT, US
International Classification:
A61K 31/52, A61P 31/22
US Classification:
5142634
Abstract:
A method for the treatment of recurrent herpes labialis in mammals, including humans, which method comprises administering to the mammal in need of such treatment, an effective amount of penciclovir or famciclovir, or a pharmaceutically acceptable salt thereof for a period of one day.